| NAME |
AMYLASE 218,000UNIT/LIPASE 40,000UNIT/PROTEASE 136,000UNIT CP,EC |
| VA GENERIC NAME |
AMYLASE/LIPASE/PROTEASE |
| DOSAGE FORM |
CAP,EC |
| FDA MED GUIDE |
Pancrelipase_(Zenpep)_(2020).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2018-01-17 00:00:00 |
| NATIONAL FORMULARY NAME |
AMYLASE/LIPASE/PROTEASE CAP,EC |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
PANCRELIPASE (EQV-ZENPEP) 40,000 EC CAP |
| VA PRODUCT IDENTIFIER |
P1111 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
CAP |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4033991 |
| EFFECTIVE DATE/TIME |
-
- 2014-12-29 00:00:00
- STATUS: ACTIVE
-
- 2018-01-17 00:00:00
- STATUS: INACTIVE
|
